Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
about
A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4Registered report: Diverse somatic mutation patterns and pathway alterations in human cancersCollagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell linesDownregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients.Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis.Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.Inhibition of cancer cell invasion and metastasis by genisteinGenome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasionA whole-genome RNA interference screen for human cell factors affecting myxoma virus replicationSuppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1)Metastasis suppressors and their roles in breast carcinoma.EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.Altered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression.MEK4 function, genistein treatment, and invasion of human prostate cancer cellsExploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies.Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update.Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.Role of the functional MKK4 promoter variant (-1304T>G) in a decreased risk of prostate cancer: case-control study and meta-analysis.MKK4 acts as a potential tumor suppressor in ovarian cancer.Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppressionJNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.MKK4 as oncogene or tumor suppressor: in cancer and senescence, the story's getting old.Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer.Metastasis suppressors: functional pathways.A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase Family.Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancers.Functional variant (-1304T>G) in the MKK4 promoter is associated with decreased risk of acute myeloid leukemia in a southern Chinese population.A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regionsUnique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays
P2860
Q21089729-80FB9D6F-B45E-463E-A9EA-1F169575663DQ28603652-496647C2-71B2-491F-BD75-46B8EF659AD3Q30441127-3AAA7190-1AF1-4455-8E7F-356EA36F923EQ33271014-1766A79C-CF92-48E8-9CC4-EE0E0B148A98Q33798359-FD7F5B84-9704-47CE-AB41-BB5E45722738Q33896649-B61885CB-597F-430C-9AB3-0EA901C0DF0CQ33901638-DF67645D-43AC-4CB0-81A1-9A43B45D86BAQ34005738-A650091C-D3B6-4E51-B431-348C5EDDCE4EQ34105995-1630EB9C-835D-4DAE-8893-9080D73B8CC0Q34332451-ED4A4456-2170-4512-B7BD-09BF8FECDF88Q34585582-1D7E3E6E-1475-4577-9996-C97427BE7D75Q35633702-B5F7E707-A815-475F-9FCB-8A0E91E82ECBQ35981102-7FF99CA0-48EF-4E91-8C0A-B3A5B82DBBD3Q36319689-C054CC83-CF70-444A-AD77-72C66316E70BQ37071712-5D1A9E22-3778-4636-AA30-C74A76E3C9FFQ37309967-C9839FF8-0DBB-43CE-B17A-281F02FE624EQ37977169-06DA6C19-FCE3-4B30-9A81-D9A27CFCC92FQ38005668-A0C16D01-8021-4887-9CBF-748D0FBF1A54Q38783344-C307EC5D-EB1A-4D2A-BF5E-AE91B4D24814Q38960209-0AE99E8D-A979-4C11-B7EC-473857A472F1Q39360462-3F0F7611-F06E-479C-9584-AECCECB2B27AQ39559505-67A3503D-7750-4045-BD73-47C28C31283AQ40351474-BBE94C26-C875-410F-8A1F-FCE92715CF69Q41193883-8E1EB1D8-5193-4CCC-8519-A6792C6CB2BCQ41308090-EBC26D69-45A6-4A43-857C-6356DBE501F7Q44573252-8171F8E3-BD0F-4DDF-9323-E2C98C79EF32Q47716769-9C589E9D-A69B-4F6E-B183-5BEAF63778A3Q48160590-C3313A8D-54E5-495E-BE84-15C83460533AQ52374520-9308B469-A46E-47DC-9448-23B92EEBF8E0Q54594575-837F9563-CEA3-4788-9AB3-E3C7C2A50DFCQ57268739-E9DA1CF7-53A0-46A9-BD2A-7EA344CDEC7CQ58051484-744A3244-209D-4E3F-919F-E9890DA379B7
P2860
Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
@en
type
label
Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
@en
prefLabel
Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
@en
P2093
P2860
P356
P1433
P1476
Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207802
P407
P577
2004-08-01T00:00:00Z
P5875
P6179
1031788486